bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc.
22211 West Interstate 10
Suite 1206
San Antonio, TX 78257
United States
210 698 5334
https://www.bioaffinitytech.com
Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Steven Girgenti | Founder & Executive Chairman of the Board | 113.75k | N/D | 1946 |
| Ms. Maria Zannes J.D. | Founder, President, CEO & Director | 299.17k | N/D | 1956 |
| Mr. Michael Dougherty CPA, M.B.A. | VP & CFO | 238.92k | N/D | 1979 |
| Mr. Xavier T. Reveles M.S. | Chief Operating Officer | N/D | N/D | 1970 |
| Dr. Vivienne I. Rebel M.D., Ph.D. | Executive VP and Chief Medical & Science Officer | 238.39k | N/D | 1966 |
| Mr. Timothy P. Zannes J.D. | Executive VP, Secretary & General Counsel | N/D | N/D | 1953 |
| Ms. Julie Anne Overton | Director of Communications | N/D | N/D | N/D |
| Mr. Dallas J. Coleman | National Director of Sales | N/D | N/D | N/D |
| Dr. William Bauta Ph.D. | Senior Vice President of Therapeutics | N/D | N/D | N/D |
Descripción
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.
Gestión corporativa
La calificación ISS Governance QuickScore de bioAffinity Technologies, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
